| 5.8 |
17.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 5.6 |
22.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 5.1 |
10.2 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 4.7 |
14.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 4.6 |
27.8 |
GO:0072049 |
comma-shaped body morphogenesis(GO:0072049) |
| 4.5 |
13.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 4.2 |
12.6 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 4.1 |
16.4 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 3.9 |
15.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 3.9 |
11.6 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 3.8 |
15.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 3.8 |
11.3 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 3.6 |
10.9 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 3.6 |
10.9 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 3.6 |
18.0 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 3.6 |
32.1 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 3.5 |
10.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 3.4 |
13.5 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 3.2 |
13.0 |
GO:0060032 |
notochord regression(GO:0060032) |
| 3.1 |
9.4 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 3.1 |
15.7 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 3.1 |
9.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 3.0 |
9.1 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 2.9 |
8.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 2.8 |
5.6 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.5 |
2.5 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 2.5 |
5.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 2.5 |
27.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 2.5 |
7.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 2.4 |
12.2 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 2.4 |
7.3 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 2.3 |
11.7 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 2.3 |
14.0 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 2.3 |
9.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.3 |
9.3 |
GO:0072191 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
| 2.3 |
6.9 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 2.3 |
6.9 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 2.2 |
13.3 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 2.2 |
8.8 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 2.2 |
2.2 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 2.2 |
17.3 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 2.1 |
21.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 2.1 |
17.0 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 2.1 |
6.3 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 2.1 |
10.5 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 2.1 |
6.2 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 2.1 |
8.3 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 2.1 |
8.3 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 2.1 |
2.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 2.1 |
8.2 |
GO:0003342 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 2.0 |
2.0 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 2.0 |
6.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 2.0 |
8.1 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 2.0 |
12.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 2.0 |
18.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 2.0 |
2.0 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 2.0 |
6.0 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 2.0 |
9.9 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 2.0 |
5.9 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 2.0 |
5.9 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.0 |
9.8 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 2.0 |
5.9 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.9 |
3.8 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.9 |
5.7 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.9 |
7.6 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.9 |
11.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.9 |
9.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.9 |
9.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.9 |
1.9 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.9 |
9.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 1.8 |
1.8 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.8 |
30.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.8 |
10.8 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.8 |
3.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 1.7 |
1.7 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 1.7 |
6.8 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.7 |
6.8 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.7 |
5.1 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 1.7 |
13.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.7 |
1.7 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 1.7 |
3.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.7 |
9.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.6 |
4.7 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 1.6 |
9.3 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.5 |
4.6 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 1.5 |
1.5 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 1.5 |
1.5 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.5 |
1.5 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.5 |
4.6 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 1.5 |
1.5 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 1.5 |
4.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.5 |
1.5 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 1.5 |
1.5 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.5 |
2.9 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 1.5 |
2.9 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 1.4 |
2.9 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 1.4 |
17.2 |
GO:0030903 |
notochord development(GO:0030903) |
| 1.4 |
4.2 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.4 |
9.8 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.4 |
2.8 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 1.4 |
1.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.4 |
8.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.4 |
1.4 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 1.4 |
4.1 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.4 |
1.4 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.3 |
9.4 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.3 |
3.9 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.3 |
3.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.3 |
9.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.3 |
3.9 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.3 |
9.0 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.3 |
3.9 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 1.3 |
3.8 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.3 |
2.5 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 1.3 |
3.8 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 1.3 |
3.8 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 1.2 |
1.2 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 1.2 |
3.7 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 1.2 |
4.9 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 1.2 |
3.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 1.2 |
3.7 |
GO:0048382 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) mesendoderm development(GO:0048382) positive regulation of cardiac ventricle development(GO:1904414) |
| 1.2 |
10.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 1.2 |
1.2 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 1.2 |
4.8 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 1.2 |
9.6 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 1.2 |
7.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 1.2 |
1.2 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 1.2 |
2.4 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 1.2 |
13.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 1.2 |
3.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.2 |
3.5 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.2 |
4.7 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.2 |
3.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.2 |
3.5 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 1.2 |
1.2 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 1.2 |
1.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.2 |
10.4 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 1.2 |
1.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.1 |
12.6 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 1.1 |
1.1 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 1.1 |
3.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.1 |
3.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 1.1 |
7.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 1.1 |
3.4 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.1 |
5.6 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.1 |
2.2 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 1.1 |
9.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.1 |
2.2 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 1.1 |
3.3 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 1.1 |
3.3 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 1.1 |
13.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.1 |
1.1 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 1.1 |
3.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 1.1 |
6.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.1 |
5.3 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.1 |
1.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.1 |
3.2 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.1 |
4.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 1.0 |
3.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 1.0 |
12.4 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 1.0 |
4.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.0 |
2.0 |
GO:1901490 |
regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 1.0 |
1.0 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.0 |
4.1 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 1.0 |
1.0 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 1.0 |
11.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 1.0 |
3.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.0 |
8.0 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 1.0 |
1.0 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 1.0 |
3.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.0 |
5.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 1.0 |
3.9 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 1.0 |
1.9 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 1.0 |
2.9 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.0 |
4.8 |
GO:0035878 |
nail development(GO:0035878) |
| 1.0 |
2.9 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.0 |
6.7 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.0 |
5.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.0 |
5.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.0 |
1.0 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.9 |
1.9 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.9 |
2.8 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.9 |
3.8 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.9 |
2.8 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.9 |
2.8 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.9 |
2.8 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.9 |
3.7 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.9 |
3.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.9 |
1.8 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.9 |
1.8 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.9 |
4.5 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.9 |
2.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.9 |
2.7 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.9 |
1.8 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.9 |
0.9 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.9 |
0.9 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.9 |
5.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.9 |
3.5 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.9 |
6.1 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.9 |
0.9 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.9 |
5.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.9 |
4.3 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 |
2.6 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.9 |
5.2 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.9 |
0.9 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.9 |
19.7 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.9 |
2.6 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.9 |
0.9 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.8 |
4.2 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.8 |
0.8 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.8 |
13.5 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.8 |
3.4 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.8 |
3.4 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.8 |
5.0 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.8 |
8.4 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.8 |
1.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.8 |
4.2 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.8 |
5.8 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.8 |
5.8 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.8 |
0.8 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.8 |
4.1 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 |
3.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.8 |
1.6 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.8 |
1.6 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.8 |
2.4 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.8 |
0.8 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.8 |
4.0 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.8 |
0.8 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.8 |
1.6 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.8 |
2.3 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.8 |
2.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.8 |
7.8 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.8 |
2.3 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.8 |
6.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.8 |
2.3 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.8 |
3.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.8 |
1.5 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.8 |
2.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 |
8.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.8 |
0.8 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.8 |
1.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 |
2.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.8 |
3.8 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.7 |
0.7 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.7 |
3.0 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.7 |
3.0 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.7 |
2.2 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.7 |
4.4 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.7 |
2.2 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.7 |
1.5 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.7 |
1.4 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.7 |
0.7 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.7 |
0.7 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.7 |
5.0 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.7 |
4.2 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.7 |
4.2 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.7 |
1.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.7 |
2.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.7 |
2.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.7 |
0.7 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.7 |
7.7 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.7 |
1.4 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.7 |
9.7 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.7 |
4.8 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.7 |
1.4 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.7 |
2.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
7.6 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.7 |
2.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.7 |
4.8 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.7 |
9.6 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.7 |
0.7 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.7 |
1.4 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.7 |
1.4 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.7 |
4.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.7 |
7.5 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.7 |
11.5 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.7 |
2.0 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.7 |
4.7 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.7 |
2.0 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.7 |
1.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.7 |
8.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.7 |
4.7 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.7 |
3.3 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.7 |
4.0 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.7 |
1.3 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.7 |
5.9 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.6 |
5.8 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.6 |
4.5 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.6 |
1.9 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.6 |
1.9 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.6 |
7.1 |
GO:2001197 |
positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 |
9.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.6 |
0.6 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.6 |
6.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 |
1.3 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.6 |
0.6 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.6 |
1.9 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.6 |
1.9 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.6 |
20.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
3.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
6.8 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.6 |
2.5 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.6 |
3.7 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.6 |
1.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.6 |
0.6 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.6 |
0.6 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.6 |
8.0 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.6 |
1.2 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.6 |
1.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.6 |
3.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.6 |
4.3 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) |
| 0.6 |
1.8 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.6 |
1.8 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.6 |
0.6 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.6 |
1.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.6 |
18.7 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.6 |
2.4 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
3.0 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.6 |
7.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.6 |
0.6 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.6 |
2.4 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.6 |
3.0 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.6 |
1.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.6 |
1.2 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.6 |
1.2 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.6 |
2.3 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 0.6 |
4.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.6 |
2.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.6 |
1.2 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.6 |
5.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.6 |
1.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.6 |
1.7 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.6 |
2.9 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.6 |
2.9 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.6 |
1.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.6 |
1.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.6 |
1.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 |
3.4 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.6 |
1.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.6 |
3.9 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.6 |
2.8 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.6 |
0.6 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.6 |
2.2 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.6 |
5.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 |
2.8 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.6 |
1.7 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.6 |
0.6 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.5 |
1.6 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 |
1.6 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.5 |
17.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.5 |
1.6 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.5 |
5.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.5 |
1.6 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.5 |
1.6 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.5 |
2.7 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 |
2.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.5 |
0.5 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.5 |
1.6 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.5 |
7.9 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.5 |
1.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.5 |
7.4 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 |
5.2 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.5 |
2.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 |
2.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 |
3.1 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
1.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 |
1.6 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.5 |
1.0 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.5 |
3.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.5 |
1.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.5 |
2.1 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.5 |
4.6 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.5 |
2.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 |
1.5 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 |
3.6 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.5 |
2.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.5 |
2.0 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.5 |
2.0 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.5 |
4.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.5 |
1.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.5 |
1.0 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
0.5 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.5 |
1.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.5 |
3.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.5 |
2.5 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.5 |
4.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.5 |
1.5 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.5 |
1.5 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.5 |
4.4 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.5 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 |
1.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
2.9 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.5 |
2.4 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.5 |
3.8 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
1.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
1.9 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.5 |
4.7 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.5 |
7.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.5 |
1.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
0.9 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.5 |
2.3 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.5 |
8.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.5 |
1.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.5 |
1.4 |
GO:1904207 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.5 |
4.2 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.5 |
1.9 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.5 |
0.9 |
GO:0033864 |
positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.5 |
0.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.5 |
1.8 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.5 |
1.4 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.5 |
0.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 |
0.5 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.5 |
1.4 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.5 |
0.5 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.5 |
1.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.5 |
1.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.5 |
1.4 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.5 |
0.5 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.5 |
1.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.4 |
2.7 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.4 |
1.3 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.4 |
1.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.4 |
7.5 |
GO:0044319 |
wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
| 0.4 |
0.9 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 |
1.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.4 |
0.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
2.6 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.4 |
1.3 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.4 |
3.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
0.9 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.4 |
0.4 |
GO:0051934 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.4 |
3.5 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
0.4 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.4 |
1.3 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.4 |
2.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
2.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.4 |
2.5 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.4 |
2.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.4 |
3.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 |
2.5 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.4 |
2.5 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.4 |
0.8 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.4 |
1.2 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.4 |
5.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.4 |
2.5 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 |
4.5 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.4 |
3.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.4 |
1.6 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.4 |
4.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.4 |
4.1 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
2.9 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.4 |
1.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.4 |
0.4 |
GO:0019230 |
proprioception(GO:0019230) |
| 0.4 |
3.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.4 |
1.6 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.4 |
0.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 |
11.3 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.4 |
14.5 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.4 |
0.8 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.4 |
1.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
1.2 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
2.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.4 |
0.4 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.4 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 |
4.4 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) |
| 0.4 |
4.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
0.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.4 |
0.4 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.4 |
1.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 |
1.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 |
2.0 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 |
3.1 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.4 |
3.5 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.4 |
1.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
15.0 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.4 |
1.5 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.4 |
0.8 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 |
8.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.4 |
5.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.4 |
1.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
0.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.4 |
1.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
4.2 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 |
4.5 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 |
5.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.4 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
1.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
3.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
1.8 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 |
2.9 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.4 |
2.6 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.4 |
0.7 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.4 |
4.0 |
GO:0014856 |
skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.4 |
1.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.4 |
0.7 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.4 |
0.4 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.4 |
4.0 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.4 |
0.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 |
0.7 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.4 |
3.2 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.4 |
1.1 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.4 |
0.7 |
GO:0040010 |
regulation of growth rate(GO:0040009) positive regulation of growth rate(GO:0040010) |
| 0.4 |
0.4 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.4 |
1.1 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.4 |
1.4 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
3.5 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.3 |
1.0 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.3 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
0.3 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.3 |
1.0 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.3 |
0.7 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.3 |
0.3 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.3 |
1.0 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.3 |
5.5 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.3 |
0.3 |
GO:0042640 |
anagen(GO:0042640) |
| 0.3 |
1.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.3 |
3.4 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.3 |
3.4 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 |
1.3 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
1.0 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.3 |
1.0 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.3 |
0.7 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) |
| 0.3 |
1.7 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.3 |
2.7 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
0.7 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
3.0 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.3 |
0.3 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.3 |
1.0 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.3 |
0.3 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.3 |
2.0 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.3 |
1.6 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
1.6 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.3 |
6.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.0 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 |
0.6 |
GO:0001774 |
microglial cell activation(GO:0001774) |
| 0.3 |
0.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
0.3 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.3 |
32.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
1.0 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.3 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
1.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
2.6 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
1.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.3 |
3.2 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.3 |
4.5 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 |
1.3 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.3 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.6 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.3 |
3.2 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.3 |
0.6 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.3 |
0.9 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
3.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
0.3 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.3 |
0.3 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.3 |
5.0 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.3 |
1.3 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 |
1.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
0.6 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.3 |
0.3 |
GO:1901201 |
regulation of extracellular matrix assembly(GO:1901201) |
| 0.3 |
1.2 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.3 |
0.6 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.3 |
2.2 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 |
4.9 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.3 |
9.4 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.3 |
0.6 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.3 |
0.3 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.3 |
0.9 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.3 |
1.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
0.3 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 |
0.6 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.3 |
2.9 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
2.1 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 |
2.4 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
0.3 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.3 |
2.0 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 |
0.3 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.3 |
5.5 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 |
0.9 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.3 |
2.6 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.3 |
1.5 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 |
2.0 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.3 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.3 |
0.3 |
GO:0034773 |
histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.3 |
0.9 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.3 |
0.9 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.3 |
0.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
2.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
0.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
3.4 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.3 |
2.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
1.4 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.3 |
0.6 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 |
1.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 |
1.4 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 |
0.8 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
1.7 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 |
5.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.3 |
0.8 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.3 |
0.6 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
0.6 |
GO:0098908 |
regulation of neuronal action potential(GO:0098908) |
| 0.3 |
3.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.3 |
2.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.3 |
2.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.3 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.3 |
0.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.3 |
0.3 |
GO:0046851 |
negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.3 |
0.8 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.3 |
0.3 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.3 |
0.5 |
GO:1902510 |
regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.3 |
1.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.3 |
1.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.3 |
4.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 |
1.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
2.7 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.3 |
3.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
1.9 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 |
1.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
0.8 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.3 |
0.5 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.3 |
0.8 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.3 |
4.0 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.3 |
1.3 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.3 |
2.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.3 |
0.8 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.3 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
0.3 |
GO:0007350 |
blastoderm segmentation(GO:0007350) |
| 0.3 |
0.8 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.3 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.3 |
0.3 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.3 |
0.3 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
1.0 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.3 |
2.9 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 |
2.6 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.3 |
0.8 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 |
1.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.3 |
0.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.3 |
0.5 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.3 |
1.0 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.3 |
1.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.3 |
1.0 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.3 |
1.0 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.3 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.5 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 |
0.8 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 |
1.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.3 |
1.5 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.3 |
0.5 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 |
0.7 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.2 |
0.7 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.2 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
0.2 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.2 |
0.7 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
0.7 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.5 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 |
0.5 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.2 |
1.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
0.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
2.7 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
2.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
1.5 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.2 |
1.4 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
0.7 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.2 |
2.4 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.2 |
1.9 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
1.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
0.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.2 |
3.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
0.5 |
GO:0002423 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.2 |
0.7 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
0.9 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.9 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.2 |
0.9 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.2 |
0.5 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.2 |
0.9 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 |
4.0 |
GO:1902850 |
microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.2 |
1.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
1.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
0.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 |
0.2 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 |
0.7 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.2 |
1.6 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.2 |
2.3 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
0.9 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
1.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.2 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.2 |
0.7 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
0.7 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 |
2.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.2 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.2 |
0.2 |
GO:1904923 |
regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
| 0.2 |
0.2 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.2 |
0.7 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.5 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
0.9 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
0.4 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
0.7 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.2 |
3.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
4.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.9 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.2 |
1.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
0.4 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.2 |
0.4 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.2 |
1.1 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 |
1.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.2 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.2 |
0.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.9 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 |
1.1 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.2 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.2 |
0.7 |
GO:0098706 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
0.6 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.2 |
0.6 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
1.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.2 |
1.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
0.4 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.2 |
0.4 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.2 |
1.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.4 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.2 |
0.2 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 |
5.6 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.2 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.8 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
2.3 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 |
1.4 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.2 |
0.6 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
0.4 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.2 |
0.4 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.4 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
1.0 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.2 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.2 |
0.4 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 |
0.6 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
6.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.2 |
3.6 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.2 |
0.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 |
0.4 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.2 |
1.0 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.2 |
0.2 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.2 |
0.8 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.2 |
1.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
1.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
0.2 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.6 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.2 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.2 |
0.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
0.4 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 |
0.6 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.6 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 |
0.6 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.2 |
0.6 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.2 |
0.6 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.2 |
1.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
1.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
0.6 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.2 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
0.2 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.2 |
1.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 |
0.6 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.2 |
2.6 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
0.6 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.5 |
GO:0031577 |
spindle checkpoint(GO:0031577) |
| 0.2 |
2.2 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
1.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 |
0.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
2.0 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.2 |
0.4 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 |
0.4 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.2 |
0.9 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
1.8 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.2 |
1.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
0.4 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.2 |
3.2 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.2 |
0.2 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.2 |
0.4 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.2 |
1.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
2.3 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
1.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
1.8 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.2 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
3.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.2 |
0.5 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.2 |
2.4 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
0.5 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.2 |
8.4 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.2 |
1.0 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.9 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.2 |
1.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
0.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.8 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.2 |
0.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
0.8 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
2.2 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.2 |
0.3 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 |
1.0 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
0.3 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.2 |
2.0 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.2 |
1.8 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.2 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
1.6 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.2 |
0.6 |
GO:0044786 |
cell cycle DNA replication(GO:0044786) |
| 0.2 |
0.2 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 |
1.8 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
1.1 |
GO:0098885 |
modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.2 |
0.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
0.3 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.2 |
0.8 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.2 |
1.4 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.2 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.3 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.8 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.2 |
0.2 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.2 |
6.2 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.2 |
0.2 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.2 |
2.2 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.2 |
0.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
0.3 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.2 |
0.3 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.2 |
1.2 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.2 |
8.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
1.6 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
10.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.2 |
4.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
1.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
0.6 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
2.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
1.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
0.2 |
GO:0032239 |
regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.2 |
1.1 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
1.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
0.8 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
1.1 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
4.2 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.2 |
0.2 |
GO:1904959 |
regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.2 |
0.5 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 |
5.9 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
0.3 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.1 |
0.4 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
0.3 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.1 |
0.4 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
2.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.3 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.3 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
0.4 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.4 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.6 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
1.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.3 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
2.9 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.1 |
1.3 |
GO:2000737 |
negative regulation of stem cell differentiation(GO:2000737) |
| 0.1 |
0.1 |
GO:0014744 |
regulation of cardiac muscle adaptation(GO:0010612) positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
0.6 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.7 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.1 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.4 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
1.0 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
1.0 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.0 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
1.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.6 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 |
0.3 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.1 |
4.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
1.5 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
1.5 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.1 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.1 |
0.8 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.1 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.7 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
0.3 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
0.4 |
GO:1902276 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
| 0.1 |
0.7 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.3 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.4 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
1.3 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.1 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.4 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.3 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.1 |
0.1 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 |
1.0 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
1.9 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.4 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.7 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.1 |
1.5 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
0.1 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.1 |
0.4 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.1 |
GO:0061217 |
regulation of mesonephros development(GO:0061217) |
| 0.1 |
0.6 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.4 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.1 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.4 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
1.0 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.6 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.4 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
2.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.8 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
0.6 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.4 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.8 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.2 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.3 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 |
0.8 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.1 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.1 |
0.1 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.1 |
0.6 |
GO:0061034 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 |
0.4 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.9 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
3.6 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 |
0.1 |
GO:0061373 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
| 0.1 |
0.3 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.1 |
0.4 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
1.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.1 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
0.3 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 |
0.1 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.2 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.9 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.5 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.9 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.2 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.6 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.3 |
GO:0060217 |
positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) |
| 0.1 |
0.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
3.2 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
0.3 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
1.3 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.1 |
0.2 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.1 |
0.3 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
1.2 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
1.5 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.1 |
1.7 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
1.7 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.7 |
GO:1902932 |
positive regulation of alcohol biosynthetic process(GO:1902932) |
| 0.1 |
1.0 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.6 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.4 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
0.3 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
1.0 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
3.0 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.1 |
0.4 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.2 |
GO:0042117 |
monocyte activation(GO:0042117) regulation of keratinocyte migration(GO:0051547) |
| 0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.3 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
0.1 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.1 |
0.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.4 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.1 |
0.2 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.1 |
0.1 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.1 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.2 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.3 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.4 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
0.3 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.4 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.5 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
1.0 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.1 |
2.7 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.2 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 |
0.4 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.1 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.2 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
0.1 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.2 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
5.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
1.1 |
GO:1904355 |
regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
1.5 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.1 |
0.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.2 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.5 |
GO:0001912 |
positive regulation of leukocyte mediated cytotoxicity(GO:0001912) positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.1 |
0.1 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
1.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.2 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.1 |
0.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.1 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.5 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
1.6 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.8 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.2 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.4 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.2 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.1 |
1.2 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
1.7 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.7 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.1 |
1.0 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.1 |
0.1 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.1 |
0.3 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
1.2 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.9 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.1 |
4.0 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.1 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
1.3 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
0.4 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.7 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
1.3 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 |
0.1 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.1 |
0.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.3 |
GO:0043247 |
telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.4 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.3 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.4 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.1 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.2 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.2 |
GO:0046822 |
regulation of nucleocytoplasmic transport(GO:0046822) |
| 0.1 |
0.1 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.1 |
0.1 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.1 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.1 |
0.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.4 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.1 |
0.1 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 |
0.7 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.3 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.1 |
0.6 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
0.1 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.1 |
GO:1902956 |
regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
| 0.1 |
0.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.2 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.1 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0090647 |
modulation of age-related behavioral decline(GO:0090647) |
| 0.1 |
0.4 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.2 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.1 |
GO:0072717 |
response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
| 0.1 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.2 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
0.3 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.2 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.1 |
0.3 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.0 |
0.8 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.1 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.4 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.2 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.3 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.0 |
0.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.4 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.2 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
| 0.0 |
0.1 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.1 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.0 |
0.2 |
GO:2000303 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 |
0.3 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.2 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.0 |
0.8 |
GO:0009410 |
response to xenobiotic stimulus(GO:0009410) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.0 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.0 |
0.2 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 |
0.3 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.3 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.0 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.0 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.0 |
0.1 |
GO:0046032 |
ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.0 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.1 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.0 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.0 |
0.0 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
1.1 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.0 |
0.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.1 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.4 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.0 |
0.2 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.0 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 |
0.2 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.0 |
0.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.2 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
1.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.2 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.0 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
2.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.1 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.0 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
1.6 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.1 |
GO:0010092 |
specification of organ identity(GO:0010092) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.0 |
0.0 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.5 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.0 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.0 |
0.1 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.0 |
0.3 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.1 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 |
0.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.0 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.8 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.2 |
GO:0033045 |
regulation of sister chromatid segregation(GO:0033045) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.0 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.0 |
0.0 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.0 |
0.5 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.3 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.2 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.5 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.0 |
GO:0071033 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.0 |
0.3 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.0 |
0.1 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.0 |
0.3 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.0 |
0.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0044033 |
multi-organism metabolic process(GO:0044033) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
1.5 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.0 |
0.1 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 |
0.4 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.0 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.2 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.0 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.0 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.0 |
0.3 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
0.6 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.1 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.0 |
0.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.2 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
